Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,175 | 68,603 | 64,941 | 64,826 | 52,264 |
| Receivables | 41,608 | 46,466 | 45,357 | 44,680 | 48,537 |
| Inventories | 18,817 | 16,226 | 13,696 | 14,268 | 12,259 |
| TOTAL | $133,549 | $137,849 | $132,262 | $126,494 | $116,692 |
| Non-Current Assets | |||||
| PPE Net | 877 | 544 | 744 | 935 | 1,133 |
| Intangibles | 185,428 | 191,712 | 197,996 | 191,617 | 199,585 |
| Other Non-Current Assets | 85,325 | 84,169 | 82,911 | 4,298 | 4,566 |
| TOTAL | $271,630 | $276,425 | $281,651 | $196,850 | $205,284 |
| Total Assets | $405,179 | $414,274 | $413,913 | $323,344 | $321,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 470 | 470 | 2,175 | 11,662 |
| Accounts payable and accrued liabilities | 11,182 | 6,173 | 5,991 | 8,374 | 9,415 |
| Accrued Expenses | 53,140 | 63,112 | 61,607 | 59,600 | 65,563 |
| Other current liabilities | 15,156 | 24,790 | 27,248 | 22,147 | 29,510 |
| TOTAL | $79,478 | $94,545 | $95,316 | $92,296 | $116,150 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,251 | 38,151 | 66,403 | 65,982 | 49,500 |
| Other Non-Current Liabilities | 33,179 | 30,914 | 26,469 | 30,151 | 27,957 |
| TOTAL | $71,430 | $69,065 | $92,872 | $96,133 | $77,457 |
| Total Liabilities | $150,908 | $163,610 | $188,188 | $188,429 | $193,607 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,770 | 3,713 | 3,707 | 3,221 | 3,213 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -314,615 | -323,085 | -319,601 | -408,154 | -412,328 |
| TOTAL | $254,271 | $250,664 | $225,725 | $134,915 | $128,369 |
| Total Liabilities And Equity | $405,179 | $414,274 | $413,913 | $323,344 | $321,976 |